• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长新冠症状的流行病学、症状学和危险因素:基于人群的多中心研究。

Epidemiology, Symptomatology, and Risk Factors for Long COVID Symptoms: Population-Based, Multicenter Study.

机构信息

Jockey Club School of Public Health & Primary Care, The Chinese University of Hong Kong, Sha Tin, China.

Centre for Health Education and Health Promotion, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, China.

出版信息

JMIR Public Health Surveill. 2023 Mar 7;9:e42315. doi: 10.2196/42315.

DOI:10.2196/42315
PMID:36645453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9994465/
Abstract

BACKGROUND

Long COVID induces a substantial global burden of disease. The pathogenesis, complications, and epidemiological and clinical characteristics of patients with COVID-19 in the acute phase have been evaluated, while few studies have characterized the epidemiology, symptomatology, and risk factors of long COVID symptoms. Its characteristics among patients with COVID-19 in the general population remain unaddressed.

OBJECTIVE

We examined the prevalence of long COVID symptoms, its symptom patterns, and its risk factors in 4 major Chinese cities in order to fill the knowledge gap.

METHODS

We performed a population-based, multicenter survey using a representative sampling strategy via the Qualtrics platform in Beijing, Shanghai, Guangzhou, and Hong Kong in June 2022. We included 2712 community-dwelling patients with COVID-19 and measured the prevalence of long COVID symptoms defined by the World Health Organization (WHO), and their risk factors. The primary outcomes were the symptoms of long COVID, with various levels of impact. A descriptive analysis of the prevalence and distribution of long COVID symptoms according to disease severity was conducted. A sensitivity analysis of increasing the number of long COVID symptoms was also conducted. Univariate and multivariate regression analyses were performed to examine the risk factors of severe long COVID symptoms, including age, gender, marital status, current occupation, educational level, living status, smoking habits, monthly household income, self-perceived health status, the presence of chronic diseases, the use of chronic medication, COVID-19 vaccination status, and the severity of COVID-19.

RESULTS

The response rate was 63.6% (n=2712). The prevalence of long COVID, moderate or severe long COVID, and severe long COVID was 90.4% (n=2452), 62.4% (n=1692), and 31.0% (n=841), respectively. Fatigue (n=914, 33.7%), cough (n=865, 31.9%), sore throat (n=841, 31.0%), difficulty in concentrating (n=828, 30.5%), feeling of anxiety (n=817, 30.2%), myalgia (n=811, 29.9%), and arthralgia (n=811, 29.9%) were the most common severe long COVID symptoms. From multivariate regression analysis, female gender (adjusted odds ratio [aOR]=1.49, 95% CI 1.13-1.95); engagement in transportation, logistics, or the discipline workforce (aOR=2.52, 95% CI 1.58-4.03); living with domestic workers (aOR=2.37, 95% CI 1.39-4.03); smoking (aOR=1.55, 95% CI 1.17-2.05); poor or very poor self-perceived health status (aOR=15.4, 95% CI 7.88-30.00); ≥3 chronic diseases (aOR=2.71, 95% CI 1.54-4.79); chronic medication use (aOR=4.38, 95% CI 1.66-11.53); and critical severity of COVID-19 (aOR=1.52, 95% CI 1.07-2.15) were associated with severe long COVID. Prior vaccination with ≥2 doses of COVID-19 vaccines was a protective factor (aOR=0.35-0.22, 95% CI 0.08-0.90).

CONCLUSIONS

We examined the prevalence of long COVID symptoms in 4 Chinese cities according to the severity of COVID-19. We also evaluated the pattern of long COVID symptoms and their risk factors. These findings may inform early identification of patients with COVID-19 at risk of long COVID and planning of rehabilitative services.

摘要

背景

长新冠导致了巨大的全球疾病负担。新冠病毒急性阶段的发病机制、并发症以及流行病学和临床特征已经得到了评估,而关于新冠病毒患者的流行病学、症状和长新冠症状的风险因素则知之甚少。其在普通人群中的特征仍未得到解决。

目的

我们通过使用代表性抽样策略,在 2022 年 6 月于北京、上海、广州和香港的 Qualtrics 平台上进行了一项基于人群的多中心调查,以填补知识空白。

方法

我们纳入了 2712 名社区居民新冠病毒患者,并测量了世界卫生组织(WHO)定义的长新冠症状的流行率及其风险因素。主要结局是长新冠症状的出现及其严重程度。根据疾病严重程度,对长新冠症状的流行率和分布进行了描述性分析。还进行了增加长新冠症状数量的敏感性分析。使用单变量和多变量回归分析来研究严重长新冠症状的风险因素,包括年龄、性别、婚姻状况、当前职业、教育程度、居住状况、吸烟习惯、月家庭收入、自我感知健康状况、慢性疾病、使用慢性药物、新冠病毒疫苗接种状况以及新冠病毒的严重程度。

结果

应答率为 63.6%(n=2712)。长新冠、中重度长新冠和重度长新冠的流行率分别为 90.4%(n=2452)、62.4%(n=1692)和 31.0%(n=841)。疲劳(n=914,33.7%)、咳嗽(n=865,31.9%)、喉咙痛(n=841,31.0%)、注意力不集中(n=828,30.5%)、焦虑感(n=817,30.2%)、肌痛(n=811,29.9%)和关节痛(n=811,29.9%)是最常见的重度长新冠症状。多变量回归分析表明,女性(调整后的优势比[aOR]=1.49,95%置信区间[CI]1.13-1.95);从事交通、物流或纪律部队工作(aOR=2.52,95%CI 1.58-4.03);与家政工人一起生活(aOR=2.37,95%CI 1.39-4.03);吸烟(aOR=1.55,95%CI 1.17-2.05);自我感知健康状况差或极差(aOR=15.4,95%CI 7.88-30.00);≥3 种慢性疾病(aOR=2.71,95%CI 1.54-4.79);慢性药物使用(aOR=4.38,95%CI 1.66-11.53);以及新冠病毒的重症程度(aOR=1.52,95%CI 1.07-2.15)与重度长新冠相关。接种≥2 剂新冠病毒疫苗是一个保护因素(aOR=0.35-0.22,95%CI 0.08-0.90)。

结论

我们根据新冠病毒的严重程度,在 4 个中国城市检查了长新冠症状的流行率。我们还评估了长新冠症状的模式及其风险因素。这些发现可能有助于早期识别有长新冠风险的新冠病毒患者,并规划康复服务。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f9/9994465/892fa422931d/publichealth_v9i1e42315_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f9/9994465/40ec655ab411/publichealth_v9i1e42315_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f9/9994465/e14b83c3804f/publichealth_v9i1e42315_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f9/9994465/892fa422931d/publichealth_v9i1e42315_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f9/9994465/40ec655ab411/publichealth_v9i1e42315_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f9/9994465/e14b83c3804f/publichealth_v9i1e42315_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85f9/9994465/892fa422931d/publichealth_v9i1e42315_fig3.jpg

相似文献

1
Epidemiology, Symptomatology, and Risk Factors for Long COVID Symptoms: Population-Based, Multicenter Study.长新冠症状的流行病学、症状学和危险因素:基于人群的多中心研究。
JMIR Public Health Surveill. 2023 Mar 7;9:e42315. doi: 10.2196/42315.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Prevalence and factors influencing long COVID among primary healthcare workers after epidemic control policy adjustment in Jiangsu, China.中国江苏疫情防控政策调整后,基层医疗卫生工作者长新冠的患病率及影响因素分析。
BMC Infect Dis. 2024 Sep 12;24(1):964. doi: 10.1186/s12879-024-09764-5.
4
Willingness to Receive COVID-19 Vaccination Among People Living With HIV and AIDS in China: Nationwide Cross-sectional Online Survey.中国 HIV 感染者和 AIDS 患者对 COVID-19 疫苗接种的意愿:全国横断面在线调查。
JMIR Public Health Surveill. 2021 Oct 21;7(10):e31125. doi: 10.2196/31125.
5
Multilevel Determinants of COVID-19 Vaccine Uptake Among South Asian Ethnic Minorities in Hong Kong: Cross-sectional Web-Based Survey.香港南亚少数族裔对 COVID-19 疫苗接种的多层次决定因素:基于网络的横断面调查。
JMIR Public Health Surveill. 2021 Nov 9;7(11):e31707. doi: 10.2196/31707.
6
Primary healthcare workers' COVID-19 infection status following implementation of adjusted epidemic prevention and control strategies: a cross-sectional study in Jiangsu, China.调整防控策略后基层医疗卫生机构工作人员新冠病毒感染现状:中国江苏的一项横断面研究。
Front Public Health. 2023 Dec 22;11:1297770. doi: 10.3389/fpubh.2023.1297770. eCollection 2023.
7
Long COVID among US adults from a population-based study: Association with vaccination, cigarette smoking, and the modifying effect of chronic obstructive pulmonary disease (COPD).基于人群的研究中美国成年人的长新冠:与疫苗接种、吸烟的关系,以及慢性阻塞性肺疾病(COPD)的修饰作用。
Prev Med. 2024 Jul;184:108004. doi: 10.1016/j.ypmed.2024.108004. Epub 2024 May 14.
8
Characteristics and predictors of Long COVID among diagnosed cases of COVID-19.COVID-19 确诊病例中 Long COVID 的特征和预测因素。
PLoS One. 2022 Dec 20;17(12):e0278825. doi: 10.1371/journal.pone.0278825. eCollection 2022.
9
Determinants of post-acute COVID-19 syndrome among hospitalized severe COVID-19 patients: A 2-year follow-up study.新冠肺炎住院患者发生新冠后综合征的决定因素:一项为期 2 年的随访研究。
PLoS One. 2024 May 10;19(5):e0298409. doi: 10.1371/journal.pone.0298409. eCollection 2024.
10
Risk factors for developing severe COVID-19 in China: an analysis of disease surveillance data.中国发生重症 COVID-19 的危险因素:疾病监测数据分析。
Infect Dis Poverty. 2021 Apr 12;10(1):48. doi: 10.1186/s40249-021-00820-9.

引用本文的文献

1
A tablet-based intervention study to alleviate cognitive and psychological symptoms in patients with post-Covid-19 condition.一项基于平板电脑的干预研究,旨在缓解新冠后综合征患者的认知和心理症状。
Front Psychol. 2025 Aug 25;16:1582742. doi: 10.3389/fpsyg.2025.1582742. eCollection 2025.
2
Mapping Long COVID: Spatial and Social Inequities Across the United States.绘制长新冠地图:美国各地的空间和社会不平等现象
medRxiv. 2025 Aug 26:2025.08.21.25334183. doi: 10.1101/2025.08.21.25334183.
3
Preliminary feasibility and clinical utility of the Unified Protocol for the transdiagnostic treatment of emotional disorders in people with long COVID-19 condition: A single case pilot study.

本文引用的文献

1
Long-term Consequences of COVID-19 and the Pandemic: Protocol for a Web-Based, Longitudinal Observational Study (DEFEAT).新冠疫情的长期后果及大流行:一项基于网络的纵向观察性研究(DEFEAT)方案
JMIR Res Protoc. 2022 Oct 26;11(10):e38718. doi: 10.2196/38718.
2
Development of a novel patient-reported outcome measure to assess signs and symptoms of COVID-19.开发一种新型患者报告结局指标以评估新型冠状病毒肺炎的体征和症状。
J Patient Rep Outcomes. 2022 Jul 29;6(1):85. doi: 10.1186/s41687-022-00471-w.
3
The Impact of COVID Vaccination on Symptoms of Long COVID: An International Survey of People with Lived Experience of Long COVID.
统一方案用于长新冠患者情绪障碍跨诊断治疗的初步可行性及临床效用:一项单病例试点研究
PLoS One. 2025 Aug 8;20(8):e0329595. doi: 10.1371/journal.pone.0329595. eCollection 2025.
4
Symptomatic Trends and Time to Recovery for Long COVID Patients Infected During the Omicron Phase.奥密克戎阶段感染的长期新冠患者的症状趋势及恢复时间
J Clin Med. 2025 Jul 11;14(14):4918. doi: 10.3390/jcm14144918.
5
Post-COVID Condition and Neuroinflammation: Possible Management with Antioxidants.新冠后状况与神经炎症:抗氧化剂的潜在治疗方法
Antioxidants (Basel). 2025 Jul 8;14(7):840. doi: 10.3390/antiox14070840.
6
Long COVID and Associated Factors Among Chinese Residents Aged 16 Years and Older in Canada: A Cross-Sectional Online Study.加拿大16岁及以上中国居民的长期新冠及其相关因素:一项横断面在线研究
Biomedicines. 2025 Apr 13;13(4):953. doi: 10.3390/biomedicines13040953.
7
[Clinical characteristics and cytokine gene expression in patients with post-COVID-19 syndrome].[新型冠状病毒肺炎后综合征患者的临床特征及细胞因子基因表达]
Rev Med Inst Mex Seguro Soc. 2025 Jan 3;63(1):e6275. doi: 10.5281/zenodo.14200098.
8
Vaccination and food consumption: association with Post-Acute COVID-19 Syndrome in Brazilian adults (CUME Study).疫苗接种与食物摄入:巴西成年人中与新冠后急性综合征的关联(CUME研究)
Front Nutr. 2025 Mar 14;12:1549747. doi: 10.3389/fnut.2025.1549747. eCollection 2025.
9
Evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition: an updated living systematic review.关于2019冠状病毒病疫苗接种与新冠后状况的关联及安全性的证据:一项更新的实时系统评价
Epidemiol Infect. 2025 Mar 31;153:e62. doi: 10.1017/S0950268825000378.
10
Long-term outcomes of post-acute sequelae of SARS-CoV-2 infection: a cohort study protocol.2019冠状病毒病感染后急性后遗症的长期结局:一项队列研究方案
Front Public Health. 2025 Mar 7;13:1533315. doi: 10.3389/fpubh.2025.1533315. eCollection 2025.
新冠疫苗接种对长期新冠症状的影响:一项针对有长期新冠亲身经历者的国际调查。
Vaccines (Basel). 2022 Apr 21;10(5):652. doi: 10.3390/vaccines10050652.
4
Differences in Clinical Presentation With Long COVID After Community and Hospital Infection and Associations With All-Cause Mortality: English Sentinel Network Database Study.社区感染和医院感染后长新冠的临床特征差异及与全因死亡率的关系:英国哨兵网络数据库研究。
JMIR Public Health Surveill. 2022 Aug 16;8(8):e37668. doi: 10.2196/37668.
5
Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study.新冠疫苗接种后长新冠症状的轨迹:基于社区的队列研究。
BMJ. 2022 May 18;377:e069676. doi: 10.1136/bmj-2021-069676.
6
Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): Rasch analysis.长新冠症状负担问卷(SBQ-LC)的编制与验证:Rasch 分析。
BMJ. 2022 Apr 27;377:e070230. doi: 10.1136/bmj-2022-070230.
7
Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID.长新冠患者单次接种疫苗后症状变化与抗体效价的关系。
J Med Virol. 2022 Jul;94(7):3416-3420. doi: 10.1002/jmv.27689. Epub 2022 Mar 8.
8
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome.急性新冠病毒感染后综合征患者前瞻性队列的肠道微生物组动态变化。
Gut. 2022 Mar;71(3):544-552. doi: 10.1136/gutjnl-2021-325989. Epub 2022 Jan 26.
9
A clinical case definition of post-COVID-19 condition by a Delphi consensus.德尔菲共识对新冠后状况的临床病例定义。
Lancet Infect Dis. 2022 Apr;22(4):e102-e107. doi: 10.1016/S1473-3099(21)00703-9. Epub 2021 Dec 21.
10
Prevalence of Long COVID symptoms in Bangladesh: a prospective Inception Cohort Study of COVID-19 survivors.孟加拉国长新冠症状的流行情况:一项针对 COVID-19 幸存者的前瞻性发病队列研究。
BMJ Glob Health. 2021 Dec;6(12). doi: 10.1136/bmjgh-2021-006838.